$407 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 21 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 27.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QDEL | Sell | QUIDEL CORP | $109,477,000 | +3.4% | 1,784,464 | -0.0% | 26.93% | +18.2% |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $80,745,000 | -19.0% | 4,348,140 | -0.2% | 19.86% | -7.4% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $76,349,000 | -23.2% | 5,036,220 | -1.8% | 18.78% | -12.2% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $74,256,000 | +1.4% | 1,779,875 | +6.4% | 18.26% | +15.9% |
| OPK | Buy | OPKO HEALTH INC | $12,144,000 | +35.0% | 5,810,376 | +57.6% | 2.99% | +54.4% |
| DERM | Buy | DERMIRA INC | $11,718,000 | -30.4% | 1,833,785 | +4.2% | 2.88% | -20.4% |
| MOTS | Buy | MOTUS GI HLDGS INC | $7,537,000 | -34.0% | 3,806,666 | +1.1% | 1.85% | -24.5% |
| SLNO | Buy | SOLENO THERAPEUTICS INC | $5,806,000 | -45.6% | 3,870,627 | +1.5% | 1.43% | -37.8% |
| PACB | PACIFIC BIOSCIENCES CALIF IN | $5,731,000 | -14.7% | 1,110,666 | 0.0% | 1.41% | -2.5% | |
| VRML | VERMILLION INC | $5,134,000 | -41.3% | 9,825,289 | 0.0% | 1.26% | -32.9% | |
| BIOL | BIOLASE INC | $4,863,000 | -36.1% | 5,173,250 | 0.0% | 1.20% | -26.9% | |
| AGEN | Buy | AGENUS INC | $4,665,000 | +10.4% | 1,808,296 | +28.3% | 1.15% | +26.2% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lput | $1,807,000 | – | 126,400 | +100.0% | 0.44% | – |
| CFRX | Sell | CONTRAFECT CORP | $1,573,000 | -51.5% | 4,392,713 | -30.9% | 0.39% | -44.5% |
| BIIB | BIOGEN INC | $1,483,000 | -0.4% | 6,368 | 0.0% | 0.36% | +14.1% | |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO Lcall | $966,000 | +39.6% | 596,000 | +29.9% | 0.24% | +59.7% |
| ATRS | New | ANTARES PHARMA INC | $964,000 | – | 288,237 | +100.0% | 0.24% | – |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INCcall | $687,000 | -15.0% | 900,100 | +400.1% | 0.17% | -2.9% |
| QDEL | New | QUIDEL CORPcall | $490,000 | – | 73,900 | +100.0% | 0.12% | – |
| AMRN | Sell | AMARIN CORP PLCcall | $108,000 | -77.4% | 120,000 | -81.6% | 0.03% | -73.8% |
| XBI | New | SPDR SERIES TRUSTcall | $51,000 | – | 250,000 | +100.0% | 0.01% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -29,653 | -100.0% | -1.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.